Market Research Logo

Meningococcal Vaccines Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

Meningococcal Vaccines Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

The report on the global meningococcal vaccines market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global meningococcal vaccines market to grow with a healthy CAGR over the forecast period from 2019-2025. The study on meningococcal vaccines market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on meningococcal vaccines market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global meningococcal vaccines market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global meningococcal vaccines market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
• The rising prevalence of meningococcal diseases
• The increasing government initiative to create awareness about meningococcal diseases
2) Restraints
• The stringent regulatory framework for vaccine approval
3) Opportunities
• Research and development happening to innovate and produce new vaccines

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global meningococcal vaccines market is segmented on the basis of type, and end-use.

The Global Meningococcal Vaccines Market by Type
• Polysaccharide Vaccines
• Conjugate Vaccines
• Combination Vaccines
• Men B Vaccines

The Global Meningococcal Vaccines Market by End-Use
• Hospital
• Pharmacies
• Retail Pharmacies
• Other End-Use

Company Profiles
The companies covered in the report include
• Bayer AG
• GlaxoSmithKline plc
• Pfizer Inc.
• Nuron Biotech Inc.
• Baxter International Inc.
• Biomed Pvt. Ltd.
• Serum Institute of India Pvt. Ltd.
• Sanofi Pasteur Inc.
• JN-International Medical Corporation
• Merck & Co., Inc.

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the meningococcal vaccines market.
2. Complete coverage of all the segments in the meningococcal vaccines market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global meningococcal vaccines market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on meningococcal vaccines market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global meningococcal vaccines market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Meningococcal Vaccines Market Highlights
2.2. Meningococcal Vaccines Market Projection
2.3. Meningococcal Vaccines Market Regional Highlights
3. Global Meningococcal Vaccines Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Type
3.4.2. IGR-Growth Matrix Analysis by End-Use
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Meningococcal Vaccines Market
4. Meningococcal Vaccines Market Macro Indicator Analysis
5. Global Meningococcal Vaccines Market by Type
5.1. Polysaccharide Vaccines
5.2. Conjugate Vaccines
5.3. Combination Vaccines
5.4. Men B Vaccines
6. Global Meningococcal Vaccines Market by End-use
6.1. Hospital
6.2. Pharmacies
6.3. Retail Pharmacies
6.4. Other End-use
7. Global Meningococcal Vaccines Market by Region 2019-2025
7.1. North America
7.1.1. North America Meningococcal Vaccines Market by Type
7.1.2. North America Meningococcal Vaccines Market by End-use
7.1.3. North America Meningococcal Vaccines Market by Country
7.2. Europe
7.2.1. Europe Meningococcal Vaccines Market by Type
7.2.2. Europe Meningococcal Vaccines Market by End-use
7.2.3. Europe Meningococcal Vaccines Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Meningococcal Vaccines Market by Type
7.3.2. Asia-Pacific Meningococcal Vaccines Market by End-use
7.3.3. Asia-Pacific Meningococcal Vaccines Market by Country
7.4. RoW
7.4.1. RoW Meningococcal Vaccines Market by Type
7.4.2. RoW Meningococcal Vaccines Market by End-use
7.4.3. RoW Meningococcal Vaccines Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Meningococcal Vaccines Market
8.2. Companies Profiles
8.2.1. Bayer AG
8.2.2. GlaxoSmithKline plc
8.2.3. Pfizer Inc.
8.2.4. Nuron Biotech Inc.
8.2.5. Baxter International Inc.
8.2.6. Biomed Pvt. Ltd.
8.2.7. Serum Institute of India Pvt. Ltd.
8.2.8. Sanofi Pasteur Inc.
8.2.9. JN-International Medical Corporation
8.2.10. Merck & Co., Inc.
9. Appendix
9.1. Primary Research Findings and Questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report